Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ON101 ointment vs Aquacel Hydrofiber dressing in chronic diabetic foot ulcers
CTR20182041Phase 3Completed
- Sponsor
- Unity Biotechnology
- Start
- Nov 2018
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Fespixon in diabetic foot ulcer (DFU), sponsored by Unity Biotechnology. Started Nov 2018; status: completed.
02
Drugs
Fespixon
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on CTR20182041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20182041.